| Source Date | Board Meeting Date | Details |
|
11-Oct-2024
|
14-Nov-2024
|
Quarterly Results
|
|
01-Aug-2024
|
09-Aug-2024
|
Quarterly Results
|
|
09-May-2024
|
22-May-2024
|
Audited Results & Final Dividend
|
|
25-Jan-2024
|
08-Feb-2024
|
Quarterly Results
|
|
29-Dec-2023
|
04-Jan-2024
|
Inter alia, to consider and approve various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue.
|
|
31-Oct-2023
|
13-Nov-2023
|
Quarterly Results
|
|
11-Oct-2023
|
16-Oct-2023
|
Inter alia, to consider the proposal for raising of fund by way of equity shares or other securities through rights issue, qualified institutions placement, preferential issue or any other method as may be permitted under the applicable law, subject to such regulatory / statutory approvals as may be required
|
|
14-Jul-2023
|
10-Aug-2023
|
Quarterly Results
|
|
04-May-2023
|
26-May-2023
|
Audited Results & Final Dividend
|
|
06-Feb-2023
|
14-Feb-2023
|
Quarterly Results
|
|
03-Nov-2022
|
14-Nov-2022
|
Quarterly Results
|
|
03-Aug-2022
|
12-Aug-2022
|
Quarterly Results
|
|
12-May-2022
|
24-May-2022
|
Dividend & Audited Results
|
|
31-Jan-2022
|
14-Feb-2022
|
Quarterly Results
|
|
01-Nov-2021
|
12-Nov-2021
|
Quarterly Results (Revised)
|
|
28-Oct-2021
|
11-Nov-2021
|
Quarterly Results
|
|
04-Aug-2021
|
13-Aug-2021
|
Quarterly Results
|
|
17-May-2021
|
24-May-2021
|
Audited Results & Final Dividend
|
|
22-Mar-2021
|
24-Mar-2021
|
inter-alia, to consider raising or borrowing monies by issue of debt instruments or securities including but not limited to issuance of rupee denominated or foreign currency denominated debt instruments/ bonds, in India or overseas, which may be issued in one or more tranches, on a private placement basis or such other methods or combinations thereof as may be decided by the Board, and that may be listed in any one or more stock exchanges in India or overseas. The above will be subject to such statutory/regulatory/corporate approvals as may be necessary under applicable laws and within the borrowings limits approved by the shareholders.
|
|
02-Feb-2021
|
12-Feb-2021
|
Quarterly Results
|